132 related articles for article (PubMed ID: 29634609)
21. Medically uncontrolled conjunctival pyogenic granulomas: correlation between clinical characteristics and histological findings.
Wu D; Qian T; Nakao T; Xu J; Liu Z; Sun X; Chu Y; Hong J
Oncotarget; 2017 Jan; 8(2):2020-2024. PubMed ID: 28008138
[TBL] [Abstract][Full Text] [Related]
22. Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension.
Easthope SE; Perry CM
Drugs Aging; 2002; 19(3):231-48. PubMed ID: 12027782
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of topical propranolol 4% gel in the treatment of pyogenic granuloma in children.
Mashiah J; Hadj-Rabia S; Slodownik D; Harel A; Sprecher E; Kutz A
J Dermatol; 2019 Mar; 46(3):245-248. PubMed ID: 30593715
[TBL] [Abstract][Full Text] [Related]
24. Latanoprostene Bunod 0.024% versus Timolol Maleate 0.5% in Subjects with Open-Angle Glaucoma or Ocular Hypertension: The APOLLO Study.
Weinreb RN; Scassellati Sforzolini B; Vittitow J; Liebmann J
Ophthalmology; 2016 May; 123(5):965-73. PubMed ID: 26875002
[TBL] [Abstract][Full Text] [Related]
25. 23-Year-old male with multiple giant facial pyogenic granulomas being treated with combined topical timolol and steroid: A case report.
Kheder K; Khaddam H; Almohi Alsaid Mushaweh H; Nabhan R
Ann Med Surg (Lond); 2022 Oct; 82():104544. PubMed ID: 36268333
[TBL] [Abstract][Full Text] [Related]
26. Pyogenic granuloma in ten children treated with topical imiquimod.
Tritton SM; Smith S; Wong LC; Zagarella S; Fischer G
Pediatr Dermatol; 2009; 26(3):269-72. PubMed ID: 19706086
[TBL] [Abstract][Full Text] [Related]
27. Treatment of a Large Nail-Bed Pyogenic Granuloma with Topical Timolol.
Frommer SA; Leathers KO
J Am Podiatr Med Assoc; 2023; 113(1):. PubMed ID: 36905620
[TBL] [Abstract][Full Text] [Related]
28. Rapid Involution of Presumed Pyogenic Granuloma with Topical Timolol.
Priluck A; Bacorn C; Rajaii F
Ophthalmology; 2023 Jan; 130(1):27. PubMed ID: 35777985
[No Abstract] [Full Text] [Related]
29. Labial pyogenic granuloma successfully treated with topical timolol in an adult.
Filippi F; Patrizi A; Veneziano L
Dermatol Ther; 2022 Apr; 35(4):e15307. PubMed ID: 34997801
[No Abstract] [Full Text] [Related]
30. A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study.
Krupin T; Liebmann JM; Greenfield DS; Ritch R; Gardiner S;
Am J Ophthalmol; 2011 Apr; 151(4):671-81. PubMed ID: 21257146
[TBL] [Abstract][Full Text] [Related]
31. Diversity of response of optic nerve head circulation to timolol maleate in gel-forming solution.
Netland PA; Schwartz B; Feke GT; Takamoto T; Konno S; Goger DG
J Glaucoma; 1999 Jun; 8(3):164-71. PubMed ID: 10376255
[TBL] [Abstract][Full Text] [Related]
32. Conservative Management of Giant Pyogenic Granuloma Post Strabismus Surgery: A Case Report and Literature Review.
Bin Dlaim MS; Alhussein GA; Alqahtani RS; Almanea LT
Cureus; 2023 Jul; 15(7):e41321. PubMed ID: 37539417
[TBL] [Abstract][Full Text] [Related]
33. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
[TBL] [Abstract][Full Text] [Related]
34. In vivo confocal microscopy of conjunctiva in preservative-free timolol 0.1% gel formulation therapy for glaucoma.
Frezzotti P; Fogagnolo P; Haka G; Motolese I; Iester M; Bagaglia SA; Mittica P; Menicacci C; Rossetti L; Motolese E
Acta Ophthalmol; 2014 Mar; 92(2):e133-40. PubMed ID: 24020826
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of Latanoprostene Bunod 0.024% Compared With Timolol 0.5% in Lowering Intraocular Pressure Over 24 Hours.
Liu JHK; Slight JR; Vittitow JL; Scassellati Sforzolini B; Weinreb RN
Am J Ophthalmol; 2016 Sep; 169():249-257. PubMed ID: 27457257
[TBL] [Abstract][Full Text] [Related]
36. Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study.
Sonty S; Mundorf TK; Stewart JA; Stewart WC
Clin Ther; 2009 Oct; 31(10):2063-71. PubMed ID: 19922877
[TBL] [Abstract][Full Text] [Related]
37. Treatment of childhood pyogenic granuloma of the nail bed with topical timolol.
Provvidenziale L; Russo F; Taddeucci P; Rubegni P
Dermatol Ther; 2020 Jul; 33(4):e13710. PubMed ID: 32472650
[No Abstract] [Full Text] [Related]
38. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.
Costagliola C; Parmeggiani F; Antinozzi PP; Caccavale A; Cotticelli L; Sebastiani A
Exp Eye Res; 2005 Nov; 81(5):610-5. PubMed ID: 15949795
[TBL] [Abstract][Full Text] [Related]
39. Latanoprost : an update of its use in glaucoma and ocular hypertension.
Perry CM; McGavin JK; Culy CR; Ibbotson T
Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627
[TBL] [Abstract][Full Text] [Related]
40. Experience with COSOPT, the fixed combination of timolol and dorzolamide, gained in Swiss ophthalmologists' offices.
Pajic B;
Curr Med Res Opin; 2003; 19(2):95-101. PubMed ID: 12740152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
